Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001104659-16-130132
Filing Date
2016-06-29
Accepted
2016-06-29 16:32:34
Documents
1
Period of Report
2016-06-24

Document Format Files

Seq Description Document Type Size
1 4/A a4a.html 4/A  
1 4/A a4a.xml 4/A 3879
  Complete submission text file 0001104659-16-130132.txt   5491
Mailing Address C/O TAMIR BIOTECHNOLOGY, INC. 11 DEER PARK DRIVE, SUITE 204 MONMOUTH JUNCTION NJ 08852
Business Address
BRANCACCIO JOHN P (Reporting) CIK: 0001276551 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-35268 | Film No.: 161739179

Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Issuer) CIK: 0001347613 (see all company filings)

IRS No.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations